The brief
- Apr 2025: announced three pups cloned from gray wolf cells with 20 edits in 14 genes chosen from ancient dire wolf DNA.
- Many scientists, including the IUCN wolf and dog experts, say they are modified gray wolves, not dire wolves.
- Reported in Jul 2026 to be raising at a $20–30B valuation, up from $10.2B in Jan 2025.
Technical approach
Read DNA from fossils
Read DNA from fossils (e.g. a 13,000-year-old dire wolf tooth) and compare it with living relatives to find genes behind key traits.
Edit the closest living animal
Make many CRISPR edits at once in cells of the nearest living species (gray wolf, Asian elephant) for coat, size and cold tolerance.
Clone with a surrogate
Put the edited cell's DNA into an egg and grow the embryo in a surrogate (dogs for the wolves). Mammoths need elephant mothers or artificial wombs.
Germline cells for dodo and moa
Birds can't be cloned this way, so Colossal grows early egg and sperm cells that can be edited and put into host embryos.
Colossal Biosciences, two programs
Updated 7 Apr 2025Research & demos
- Apr 2025
Colossal's analysis of the dire wolf genome behind its edit choices.
- Mar 2025paperMultiplex-edited mice recapitulate woolly mammoth hair phenotypes (preprint) (opens doi.org)Woolly mammoth
Many edits at once to hair and fat genes gave mice long, woolly coats.
Open technical problems
- What counts as de-extinctionOpen
A few edits recreate some traits, not the extinct animal's genome, behavior or role in nature; the claim is disputed.
- Elephant reproductionActive research
Asian elephants are endangered and pregnant for ~22 months; lab-made elephant cells and artificial wombs aren't ready.
- Animal welfare and ecologyOpen
Raising social animals without natural parents, and any release into the wild, raise questions no rules cover yet.
Upcoming catalysts
- 2028Target birth of first mammoth-trait calfWoolly mammothby ~27 mo
Company & funding
- Valuation
- $10Bprivate
- Raised
- $350Mdisclosed private rounds
- Last round
- Series CJan 2025
- HQ
- US
- Founded
- 2021
| Date | Round | Amount | Post-money | Lead |
|---|---|---|---|---|
| Jan 2025 | Series C | $200M | $10B | TWG Global |
| Jan 2023 | Series B | $150M | — | US Innovative Technology Fund |
Partners & customers
- Partner
Software spinout for computational biology.
- InvestorTWG Global
Led the Jan 2025 Series C.
- Partner
Thylacine research partnership.
People
- Ben Lamm (opens en.wikipedia.org)Co-founder and CEO
- George Church (opens en.wikipedia.org)Co-founder
- Beth Shapiro (opens en.wikipedia.org)Chief Science Officer


